Vimarsana
Biggest News Aggregation in the World

Longitudinal Analysis News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Longitudinal Analysis. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Longitudinal Analysis Today - Breaking & Trending Today

Skeptical Science New Research for Week #7 2024 - Vimarsana News

Skeptical Science New Research for Week #7 2024

Open access notables Physics-based early warning signal shows that AMOC is on tipping course, van Westen et al., Science Advances:

Owners prove astute observers of asthma signs in horses - study - Vimarsana News

Owners prove astute observers of asthma signs in horses - study

Veterinarians could leverage the feedback from owners, who have observed their horses over time, to assist them in making a diagnosis.

iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data - Vimarsana News

iFR and FFR are equally safe to diagnose and treat heart disease according to largest-ever analysis of new real-world, long-term data

Philips iFR iFR co-registration October 26, 2023 Safety of Philips’ iFR in the guidance of percutaneous coronary intervention (PCI) for heart disease demonstrated in late-breaking science at TCT 2023 highlighting patient-level outcomes analysis of 42,000 patients from the National Swedeheart Quality RegistryPrevious data demonstrate that iFR delivers consistent patient outcomes, reduces discomfort and offers a more cost-effective and faster diagnostic solution [1,2] compared to FFR Amsterdam, th

Source: yahoo.com
TXST study shows veterans experience more health issues - Vimarsana News

TXST study shows veterans experience more health issues

U.S. military veterans historically suffer worse overall health than other Americans.[San Marcos, TX] [Hays County news] News San Marcos News, San Marcos Record [Texas State]

Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress - Vimarsana News

Data from Across Incyte's Oncology Portfolio Accepted for Presentation at the 2023 ASCO Annual Meeting and EHA2023 Hybrid Congress

Incyte today announced that multiple abstracts featuring data from across its oncology portfolio will be presented at the upcoming 2023 American Society of Clinical Oncology Annual Meeting held... | May 25, 2023